These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1302300)

  • 1. Brain aluminum in Alzheimer's disease using an improved GFAAS method.
    Xu N; Majidi V; Markesbery WR; Ehmann WD
    Neurotoxicology; 1992; 13(4):735-43. PubMed ID: 1302300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laser microprobe analysis of brain aluminum in Alzheimer's disease.
    Lovell MA; Ehmann WD; Markesbery WR
    Ann Neurol; 1993 Jan; 33(1):36-42. PubMed ID: 8257483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain interleukin-1 beta in Alzheimer's disease and vascular dementia.
    Cacabelos R; Alvarez XA; Fernández-Novoa L; Franco A; Mangues R; Pellicer A; Nishimura T
    Methods Find Exp Clin Pharmacol; 1994 Mar; 16(2):141-51. PubMed ID: 8007743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Instrumental neutron activation analysis of brain aluminum in Alzheimer disease and aging.
    Markesbery WR; Ehmann WD; Hossain TI; Alauddin M; Goodin DT
    Ann Neurol; 1981 Dec; 10(6):511-6. PubMed ID: 7325600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aluminum exposure through the diet: metal levels in AbetaPP transgenic mice, a model for Alzheimer's disease.
    Gómez M; Esparza JL; Cabré M; García T; Domingo JL
    Toxicology; 2008 Jul; 249(2-3):214-9. PubMed ID: 18571827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The comparison of the regional cerebral metabolism rate of glucose in Alzheimer's disease with mild cognitive impairment].
    Cao Q; Jiang K; Liu Y; Zhang M; Xiao S; Zuo C; Huang H
    Zhonghua Yi Xue Za Zhi; 2002 Dec; 82(23):1613-6. PubMed ID: 12667368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional distribution of brain gangliosides in Alzheimer's disease.
    Kalanj S; Kracun I; Rosner H; Cosović C
    Neurol Croat; 1991; 40(4):269-81. PubMed ID: 1751644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in regional and subcellular localization of G(q/11) and RGS4 protein levels in Alzheimer's disease: correlation with muscarinic M1 receptor binding parameters.
    Muma NA; Mariyappa R; Williams K; Lee JM
    Synapse; 2003 Jan; 47(1):58-65. PubMed ID: 12422374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain trace elements in Alzheimer's disease.
    Ehmann WD; Markesbery WR; Alauddin M; Hossain TI; Brubaker EH
    Neurotoxicology; 1986; 7(1):195-206. PubMed ID: 3714121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the severity of neuropathologic changes in familial and sporadic Alzheimer's disease.
    Nochlin D; van Belle G; Bird TD; Sumi SM
    Alzheimer Dis Assoc Disord; 1993; 7(4):212-22. PubMed ID: 8305189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aluminum levels in brain in Alzheimer's disease.
    Trapp GA; Miner GD; Zimmerman RL; Mastri AR; Heston LL
    Biol Psychiatry; 1978 Dec; 13(6):709-18. PubMed ID: 737258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional brain trace-element studies in Alzheimer's disease.
    Thompson CM; Markesbery WR; Ehmann WD; Mao YX; Vance DE
    Neurotoxicology; 1988; 9(1):1-7. PubMed ID: 3393299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes of neurocalcin, a calcium-binding protein, in the brain of patients with Alzheimer's disease.
    Shimohama S; Chachin M; Taniguchi T; Hidaka H; Kimura J
    Brain Res; 1996 Apr; 716(1-2):233-6. PubMed ID: 8738246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidation of thiol-proteases in the hippocampus of Alzheimer's disease.
    Marcum JL; Mathenia JK; Chan R; Guttmann RP
    Biochem Biophys Res Commun; 2005 Aug; 334(2):342-8. PubMed ID: 16018967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clusterin (apolipoprotein J) protein levels are increased in hippocampus and in frontal cortex in Alzheimer's disease.
    Lidström AM; Bogdanovic N; Hesse C; Volkman I; Davidsson P; Blennow K
    Exp Neurol; 1998 Dec; 154(2):511-21. PubMed ID: 9878186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The neural correlates of verbal short-term memory in Alzheimer's disease: an fMRI study.
    Peters F; Collette F; Degueldre C; Sterpenich V; Majerus S; Salmon E
    Brain; 2009 Jul; 132(Pt 7):1833-46. PubMed ID: 19433442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Content of brain aluminum is not elevated in Alzheimer disease.
    Bjertness E; Candy JM; Torvik A; Ince P; McArthur F; Taylor GA; Johansen SW; Alexander J; Grønnesby JK; Bakketeig LS; Edwardson JA
    Alzheimer Dis Assoc Disord; 1996; 10(3):171-4. PubMed ID: 8876778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Application of solid sampling graphite furnace atomic absorption spectrophotometry to mensuration of brain iron content in rats].
    Zhang N; Sheng QH; Shi ZH; Zhang ZG; Duan XL; Chang YZ
    Guang Pu Xue Yu Guang Pu Fen Xi; 2009 Apr; 29(4):1127-30. PubMed ID: 19626918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of aluminium in samples from bone and liver of elderly Norwegians.
    Hongve D; Johansen S; Andruchow E; Bjertness E; Becher G; Alexander J
    J Trace Elem Med Biol; 1996 Apr; 10(1):6-11. PubMed ID: 8793817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A reexamination of aluminum in Alzheimer's disease: analysis by energy dispersive X-ray microprobe and flameless atomic absorption spectrophotometry.
    Jacobs RW; Duong T; Jones RE; Trapp GA; Scheibel AB
    Can J Neurol Sci; 1989 Nov; 16(4 Suppl):498-503. PubMed ID: 2804812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.